{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:23:04Z","timestamp":1772119384486,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00520-024-08858-9","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T21:02:06Z","timestamp":1725915726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Questionnaire survey of healthcare professionals on taxane-induced nail change in Japan"],"prefix":"10.1007","volume":"32","author":[{"given":"Kazumasa","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyomi","family":"Nonogaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohji","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Kizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobukazu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"8858_CR1","doi-asserted-by":"publisher","first-page":"11575","DOI":"10.1038\/s41598-022-13327-6","volume":"12","author":"A Morrison","year":"2022","unstructured":"Morrison A, Marshall-McKenna RM, McFadyen AK et al (2022) A randomised controlled trial of interventions for taxane-induced nail toxicity in women with early breast cancer. Sci Rep 12:11575. https:\/\/doi.org\/10.1038\/s41598-022-13327-6","journal-title":"Sci Rep"},{"key":"8858_CR2","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/pon.3268","volume":"22","author":"K Nozawa","year":"2013","unstructured":"Nozawa K, Shimizu C, Kakimoto M et al (2013) Quantitative assessment of appearance changes and related distress in cancer patients. Psychooncology 22:2140\u20132147. https:\/\/doi.org\/10.1002\/pon.3268","journal-title":"Psychooncology"},{"key":"8858_CR3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaad.2014.03.019","volume":"71","author":"KK Miller","year":"2014","unstructured":"Miller KK, Gorcey L, McLellan BN (2014) Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management. J Am Acad Dermatol 71:787\u2013794. https:\/\/doi.org\/10.1016\/j.jaad.2014.03.019","journal-title":"J Am Acad Dermatol"},{"key":"8858_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/annonc\/mdg050","volume":"14","author":"AM Minisini","year":"2003","unstructured":"Minisini AM, Tosti A, Sobrero AF et al (2003) Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol 14:333\u2013337. https:\/\/doi.org\/10.1093\/annonc\/mdg050","journal-title":"Ann Oncol"},{"key":"8858_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/bjd.13743","volume":"173","author":"K Capriotti","year":"2015","unstructured":"Capriotti K, Capriotti JA, Lessin S et al (2015) The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis. Br J Dermatol 173:842\u2013845. https:\/\/doi.org\/10.1111\/bjd.13743","journal-title":"Br J Dermatol"},{"key":"8858_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1078155208100450","volume":"15","author":"P Gilbar","year":"2009","unstructured":"Gilbar P, Hain A, Peereboom VM (2009) Nail toxicity induced by cancer chemotherapy. J Oncol Pharm Pract 15:143\u2013155. https:\/\/doi.org\/10.1177\/1078155208100450","journal-title":"J Oncol Pharm Pract"},{"key":"8858_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/s0140-6736(00)04210-0","volume":"357","author":"G Wasner","year":"2001","unstructured":"Wasner G, Hilpert F, Baron R, Pfisterer J (2001) Clinical picture: nail changes secondary to docetaxel. Lancet 357:910. https:\/\/doi.org\/10.1016\/s0140-6736(00)04210-0","journal-title":"Lancet"},{"key":"8858_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF00192885","volume":"73","author":"EJ Battegay","year":"1995","unstructured":"Battegay EJ (1995) Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med (Berl) 73:333\u2013346. https:\/\/doi.org\/10.1007\/BF00192885","journal-title":"J Mol Med (Berl)"},{"key":"8858_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1684\/ejd.2016.2833","volume":"26","author":"V Sibaud","year":"2016","unstructured":"Sibaud V, Leb\u0153uf NR, Roche H et al (2016) Dermatological adverse events with taxane chemotherapy. Eur J Dermatol 26:427\u2013443. https:\/\/doi.org\/10.1684\/ejd.2016.2833","journal-title":"Eur J Dermatol"},{"issue":"4","key":"8858_CR10","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/S1470-2045(14)71133-7","volume":"16","author":"C Robert","year":"2015","unstructured":"Robert C, Sibaud V, Mateus C et al (2015) Nail toxicities induced by systemic anticancer treatments. Lancet Oncol 16(4):e181-189. https:\/\/doi.org\/10.1016\/S1470-2045(14)71133-7","journal-title":"Lancet Oncol"},{"key":"8858_CR11","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1200\/JCO.2005.15.651","volume":"23","author":"F Scott\u00e9","year":"2005","unstructured":"Scott\u00e9 F, Tourani JM, Banu E et al (2005) Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol 23:4424\u20134429. https:\/\/doi.org\/10.1200\/JCO.2005.15.651","journal-title":"J Clin Oncol"},{"key":"8858_CR12","unstructured":"Japanese Appearance Care Guidelines Committee (2021) Nihon no Appearansu Kea gaidorain (Japanese Guidelines for Appearance Care). [In Japanese]. Available at: http:\/\/jascc.jp\/wp\/wp-content\/uploads\/2022\/01\/73b82f45371e2f820547c24d8ceb5b90-1.pdf"},{"key":"8858_CR13","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/jamadermatol.2018.3465","volume":"154","author":"DH Marks","year":"2018","unstructured":"Marks DH, Qureshi A, Friedman A (2018) Evaluation of prevention interventions for taxane-induced dermatologic adverse events: a systematic review. JAMA Dermatol 154:1465\u20131472. https:\/\/doi.org\/10.1001\/jamadermatol.2018.3465","journal-title":"JAMA Dermatol"},{"key":"8858_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.clindermatol.2013.06.013","volume":"31","author":"BM Piraccini","year":"2013","unstructured":"Piraccini BM, Alessandrini A (2013) Drug-related nail disease. Clin Dermatol 31:618\u2013626. https:\/\/doi.org\/10.1016\/j.clindermatol.2013.06.013","journal-title":"Clin Dermatol"},{"key":"8858_CR15","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/cncr.23333","volume":"112","author":"F Scott\u00e9","year":"2008","unstructured":"Scott\u00e9 F, Banu E, Medioni J et al (2008) Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot. Cancer 112:1625\u20131631. https:\/\/doi.org\/10.1002\/cncr.23333","journal-title":"Cancer"},{"key":"8858_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejon.2011.06.007","volume":"16","author":"G Can","year":"2012","unstructured":"Can G, Aydiner A, Cavdar I (2012) Taxane-induced nail changes: predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity. Eur J Oncol Nurs 16:270\u2013275. https:\/\/doi.org\/10.1016\/j.ejon.2011.06.007","journal-title":"Eur J Oncol Nurs"},{"key":"8858_CR17","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00520-013-2095-x","volume":"22","author":"AL McCarthy","year":"2014","unstructured":"McCarthy AL, Shaban RZ, Gillespie K, Vick J (2014) Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial. Support Care Cancer 22:1375\u20131383. https:\/\/doi.org\/10.1007\/s00520-013-2095-x","journal-title":"Support Care Cancer"},{"key":"8858_CR18","doi-asserted-by":"publisher","first-page":"e13118","DOI":"10.1111\/ecc.13118","volume":"28","author":"KL Huang","year":"2019","unstructured":"Huang KL, Lin KY, Huang TW et al (2019) Prophylactic management for taxane-induced nail toxicity: a systematic review and meta-analysis. Eur J Cancer Care (Engl) 28:e13118. https:\/\/doi.org\/10.1111\/ecc.13118","journal-title":"Eur J Cancer Care (Engl)"},{"key":"8858_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000497824","volume":"5","author":"A Alessandrini","year":"2019","unstructured":"Alessandrini A, Starace M, Cer\u00e8 G, Brandi N, Piraccini BM (2019) Management and outcome of taxane-induced nail side effects: experience of 79 patients from a single centre. Skin Appendage Disord 5:276\u2013282. https:\/\/doi.org\/10.1159\/000497824","journal-title":"Skin Appendage Disord"},{"key":"8858_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-4632.2011.05082.x","volume":"51","author":"AM Wnorowski","year":"2012","unstructured":"Wnorowski AM, de Souza AD, Chachoua A, Cohen DE (2012) The management of EGFR inhibitor adverse events: a case series and treatment paradigm. Int J Dermatol 51:223\u2013232. https:\/\/doi.org\/10.1111\/j.1365-4632.2011.05082.x","journal-title":"Int J Dermatol"},{"key":"8858_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jaad.2013.02.025","volume":"69","author":"Y Kiyohara","year":"2013","unstructured":"Kiyohara Y, Yamazaki N, Kishi A (2013) Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer. J Am Acad Dermatol 69:463\u2013472. https:\/\/doi.org\/10.1016\/j.jaad.2013.02.025","journal-title":"J Am Acad Dermatol"},{"key":"8858_CR22","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1200\/JCO.2008.21.7828","volume":"28","author":"ME Lacouture","year":"2010","unstructured":"Lacouture ME, Mitchell EP, Piperdi B et al (2010) Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-emptive skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer. J Clin Oncol 28:1351\u20131357. https:\/\/doi.org\/10.1200\/JCO.2008.21.7828","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08858-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08858-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08858-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T11:07:45Z","timestamp":1729336065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08858-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["8858"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08858-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3931203\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"5 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This survey was not conducted on patients and was not subject to the \u201cEthical Guidelines for Medical and Health Research Involving Human Subjects\u201d in Japan. The survey was conducted in compliance with the \u201cAct on the Protection of Personal Information,\u201d taking into consideration the handling of personal and other information of the respondents and medical professionals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent for survey participation was obtained from all survey respondents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Consent for publication was obtained from all survey respondents for consent to publish the results. Respondents were assured that their responses would be kept confidential.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"647"}}